Evidence map›Paper›PMID 42009654›Full record

ArticleNature communications2026

Hotspot pocket-based discovery of urea transporter selective inhibitors.

Lei Liu, Zhi Li, Chao Zhang, Yan Zhang, Zhizhen Huang, Daolai Zhang, Dongfang Li, Juanjuan Zhao, Yuhao Miao, Boyang Cai and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lei Liu *State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou, China.
Zhi Li *Jiangsu Key Laboratory of Geriatric Precision Medicine and Aging Intervention, Xuzhou Medical University, Xuzhou, Jiangsu, P. R. China.
Chao Zhang *Institute of Brain Science and Brain-inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, PR China.ORCID http://orcid.org/0000-0001-8760-0110
Yan Zhang *School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Shandong Medical and Pharmaceutical University, Yantai, China.
Zhizhen Huang *Department of Pharmacology, School of Basic Medical Sciences, State Key Laboratory of Natural and Biomimetic Drugs, and State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
Daolai ZhangSchool of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Shandong Medical and Pharmaceutical University, Yantai, China.
Dongfang LiState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou, China.
Juanjuan ZhaoSchool of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Shandong Medical and Pharmaceutical University, Yantai, China.
Yuhao MiaoSchool of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Shandong Medical and Pharmaceutical University, Yantai, China.
Boyang CaiDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Key Laboratory of Cardiovascular Receptors Research, Peking University, Beijing, China.
Kongkai ZhuAdvanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Jin-Peng SunAdvanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.ORCID http://orcid.org/0000-0003-3572-1580
Guige HouSchool of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Shandong Medical and Pharmaceutical University, Yantai, China. guigehou@163.com.
Ying SunJiangsu Key Laboratory of Geriatric Precision Medicine and Aging Intervention, Xuzhou Medical University, Xuzhou, Jiangsu, P. R. China. yingsun@xzhmu.edu.cn.ORCID http://orcid.org/0000-0002-1720-8540
Baoxue YangMedical Innovation Center (Taizhou) of Peking University, Taizhou, China. baoxue@bjmu.edu.cn.
Xiao YuKey Laboratory Experimental Teratology of the Ministry of Education and Department of Physiology, School of Basic Medical Sciences, Shandong University, Jinan, China. yuxiao@sdu.edu.cn.ORCID http://orcid.org/0000-0003-1119-8334
Shenming HuangState Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou, China. huangshenming@jnu.edu.cn.ORCID http://orcid.org/0000-0002-5322-7220

Funding

China National Funds for Distinguished Young Scientists 82225011Government of Jiangsu Province (Jiangsu Province) LCZX202403Guangzhou Science and Technology Program key projects 202102070001National Natural Science Foundation of China (National Science Foundation of China) 82273999National Natural Science Foundation of China (National Science Foundation of China) 82304601National Natural Science Foundation of China (National Science Foundation of China) 92057121Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2024QH104Peking University (PKU) 202409Peking University (PKU) 202410
6 · The paper itself

Abstract

Urea transporter (UT) inhibitors are a promising class of diuretics, as selective inhibitors targeting UT-A subtypes have demonstrated considerable therapeutic potential. Herein, we employ a two-round progressive hotspot pocket-based virtual screening approach combined with biological validation to identify M353-0039 as a highly potent and selective inhibitor of UT-A2. We conduct cryo-electron microscopy to solve the structures of UT-A2 bound with the two inhibitors, M353-0039 and E822-1968, at the resolution of 2.7 Å and 2.9 Å respectively, and elucidate the structural mechanism underlying the superior efficacy and selectivity of M353-0039. Compared with the inhibitor HQA2 and E822-1968, M353-0039 occupies a deeper binding pocket and forms more interactions with UT-A2, thus leading to greater inhibitory potency. We demonstrate that the selectivity of M353-0039 is driven by the nonconserved residues C285 and G322 within the "T-T" subpocket of UT-A2. Finally, we validate the selective effects of M353-0039 in inhibiting UT-A2 function both in mouse models and hepatic cell. These findings not only identify a selective inhibitor as a tool that can be applied to elucidate the unique physiological roles of UT-A2 but also provide an available method for efficiently developing UT-A-selective inhibitors with potent activity as the next-generation diuretics.

Indexed as

DiureticsMembrane Transport ProteinsAnimalsBinding SitesCryoelectron MicroscopyHumansMiceModels, MolecularUrea TransportersDiureticsMembrane Transport ProteinsUrea Transporters

Identifiers

PMID42009654
PMCPMC13279936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.